| Literature DB >> 33242695 |
Eline van Overbeeke1, Sissel Michelsen2, Mondher Toumi3, Hilde Stevens4, Mark Trusheim5, Isabelle Huys6, Steven Simoens6.
Abstract
This review can inform gene therapy developers on challenges that can be encountered when seeking market access. Moreover, it provides an overview of trends among challenges and potential solutions.Entities:
Mesh:
Year: 2020 PMID: 33242695 DOI: 10.1016/j.drudis.2020.11.024
Source DB: PubMed Journal: Drug Discov Today ISSN: 1359-6446 Impact factor: 7.851